<DOC>
	<DOCNO>NCT01468064</DOCNO>
	<brief_summary>The purpose study evaluate feasibility , efficacy , safety autologous transplantation ex vivo expand bone marrow stromal cell ( BMSCs ) endothelial progenitor cell ( EPCs ) treatment patient ischemic stroke .</brief_summary>
	<brief_title>Autologous Bone Marrow Stromal Cell Endothelial Progenitor Cell Transplantation Ischemic Stroke</brief_title>
	<detailed_description>This study multi-center , single-blind , randomize , parallel control trail . Patients acute cerebral infarct within middle cerebral arterial territory severe neurological deficit enrol randomly allocate 3 group : autologous BMSCs transplantation group , autologous EPCs transplantation group Placebo control group . Randomization code establish study statistician reveal stem cell laboratory technician responsible separate cell aliquot prepare placebo material . All patient undergo Bone Marrow aspiration procedure 7 day symptom onset . BMSCs EPCs expand ex vivo intravenously infuse body , respectively . The control group receive cell therapy . Observe follow 1 year onset . Neurological score , neuroimaging , mortality cause , side effect , new-onset comorbidities monitor compare group .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>1 . Patients age 18 80 year , within 7 day onset symptom 2 . Ischemic lesion within MCA territory assess use diffusionweighted imaging ( DWI ) 3 . The National Institutes Health Stroke Scale ( NIHSS ) â‰¥ 7 day 7 onset 4 . Signed informed consent 1 . Lacunar syndrome 2 . Diagnosis ischemic stroke ( eg . Intracranial hemorrhage Intracranial tumor ) 3 . Hematological cause stroke 4 . Severe respiratory , hepatic , renal disorder 5 . Presence severe febrile illness viral disease 6 . Malignant diseases 7 . Presence autoimmune diseases 8 . Positive response penicillin skin test , multiple drug allergy 9 . Breastfeeding pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Stroke</keyword>
	<keyword>Infarction , Middle Cerebral Artery</keyword>
	<keyword>Cerebral Infarction</keyword>
	<keyword>Cerebrovascular Accident</keyword>
	<keyword>Stem Cell Transplantation</keyword>
	<keyword>Mesenchymal Stem Cell Transplantation</keyword>
	<keyword>Bone marrow stromal cell</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>Endothelial progenitor cell</keyword>
	<keyword>Adult Stem Cells</keyword>
	<keyword>Cell Therapy</keyword>
</DOC>